Preclinical studies in animal models have shown that mini-dystrophin and micro-dystrophin can partially restore muscle function and significantly reduce muscle degeneration, indicating that these truncated versions of dystrophin can be therapeutically effective in DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.